These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21178856)

  • 1. Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option?
    Kundel Y; Brenner R; Purim O; Peled N; Idelevich E; Fenig E; Sulkes A; Brenner B
    Dis Colon Rectum; 2010 Dec; 53(12):1624-31. PubMed ID: 21178856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?
    Tulchinsky H; Rabau M; Shacham-Shemueli E; Goldman G; Geva R; Inbar M; Klausner JM; Figer A
    Ann Surg Oncol; 2006 Mar; 13(3):347-52. PubMed ID: 16450221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
    Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer.
    Frasson M; Garcia-Granero E; Roda D; Flor-Lorente B; Roselló S; Esclapez P; Faus C; Navarro S; Campos S; Cervantes A
    Cancer; 2011 Jul; 117(14):3118-25. PubMed ID: 21264832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploration on neoadjuvant chemoradiation in the treatment for locally advanced low rectal cancer].
    Yu BM; Zhang M; Peng LH; Bian GW; Wu WQ; Chen LW; Fu J; Fei CS
    Zhonghua Wai Ke Za Zhi; 2009 Oct; 47(20):1540-3. PubMed ID: 20092741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of neoadjuvant radio-chemotherapy in the treatment of rectal cancer].
    Staudacher C; Di Palo S; Tamburini AM; Vignali A; Orsenigo E
    Ann Ital Chir; 2007; 78(6):493-8. PubMed ID: 18510028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period.
    Habr-Gama A; Perez RO; Sabbaga J; Nadalin W; São Julião GP; Gama-Rodrigues J
    Dis Colon Rectum; 2009 Dec; 52(12):1927-34. PubMed ID: 19934911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.
    Kalady MF; de Campos-Lobato LF; Stocchi L; Geisler DP; Dietz D; Lavery IC; Fazio VW
    Ann Surg; 2009 Oct; 250(4):582-9. PubMed ID: 19710605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
    de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Geisler D; Dietz DW; Lavery IC; Fazio VW; Kalady MF
    Ann Surg Oncol; 2011 Jun; 18(6):1590-8. PubMed ID: 21207164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
    Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival].
    Farnault B; Moureau-Zabotto L; de Chaisemartin C; Esterni B; Lelong B; Viret F; Giovannini M; Monges G; Delpero JR; Bories E; Turrini O; Viens P; Resbeut M
    Cancer Radiother; 2011 Jul; 15(4):279-86. PubMed ID: 21515083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
    Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R
    Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative chemoradiation therapy for lower rectal cancer].
    Murotani M; Tsujinaka T; Takami M; Takada T; Kitada M; Tsukahara Y; Shibata T; Niinobu T; Iihara K; Tsukamoto F; Ogawa M; Kimura M; Nose T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1482-5. PubMed ID: 8854786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.